Abstract
In this paper, a novel neural network is proposed based on quantum rotation gate and controlled- NOT gate. Both the input layer and the hide layer are quantum-inspired neurons. The input is given by qubits, and the output is the probability of qubit in the state. By employing the gradient descent method, a training algorithm is introduced. The experimental results show that this model is superior to the common BP networks in Quantum-Inspired Neural Networks with Application in silico drug-target flexibility complement methodology-design for the generation of a peptide-mimic novel pharmacoelement binding to the amino acid conserved sequences of the active loop of a Haemophilus influenzae porin P2.
Keywords
Quantum-Inspired,Neural Networks;Application;rational in silico;drug-target;flexibility;complement methodology-design;generation peptide-mimic;novel pharmacoelement;binding amino acid;conserved sequences; active loop; Haemophilus influenzae porin P2.
Article Type
Research Article - Abstract
Publication history
Received: Sep 20, 2017
Accepted: Sep 25, 2017
Published: Oct 01, 2017
Citation
Grigoriadis Ioannis, Grigoriadis George, Grigoriadis Nikolaos, George Galazios (2017) Quantum-Inspired Neural Networks with Application in silico drug-target flexibility complement methodology-design for the generation of a peptide-mimic novel pharmacoelement binding to the amino acid conserved sequences of the active loop of a Haemophilus influenzae porin P2.
Authors Info
Grigoriadis Nikolaos
Department of IT Computer Aided Personalized Myoncotherapy, Cartigenea-Cardiogenea, Neurogenea-Cellgenea, Cordigenea-HyperoligandorolTM,
Biogenea Pharmaceuticals Ltd,
Thessaloniki, Greece;
Grigoriadis Ioannis
Department of Computer Drug Discovery Science, BiogenetoligandorolTM,
Biogenea Pharmaceuticals Ltd,
Thessaloniki, Greece;
Grigoriadis George
Department of Stem Cell Bank and ViroGeneaTM,
Biogenea Pharmaceuticals Ltd,
Thessaloniki, Greece;
George Galazios
Professor of Obstetrics and Gynecology,
Democritus University of Thrace,
Komotini, Greece;
E-mail: biogeneadrug@gmail.com